Mandy Du
Education
Ph.D., biostatistics, Boston University; M.S., biostatistics, Yale University; B.S., applied mathematics, and B.A., psychology, University of California, San Diego
Summary of Experience
Dr. Du is experienced in developing and applying novel statistical methods in the field of health economics and outcomes research (HEOR). She has a wide range of experience developing and guiding the implementation of analytic study cycles, including claims data analysis, chart review, clinical trial analysis, cost-effectiveness analysis, and indirect treatment comparison. Her work covers a broad range of disease areas such as oncology, hematology, immunology, psychiatry, and women’s health. Dr. Du’s work has been published in peer-reviewed clinical and health economics journals and presented at clinical and economic research conferences.
-
Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia Gravis
Advances in Therapy, October 2024
2024Smith AG, Wolfe GI, Habib AA, Qi CZ, Yang H, Du M, Chen X, Gelinas D, Brauer E, Phillips G, Saccà F